BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND LZTR1, ENSG00000099949, 8216, Q8N653, TCFL2, MGC21205, LZTR-1
62 results:

  • 1. Genome-wide association analysis identifies a susceptibility locus for sporadic vestibular schwannoma at 9p21.
    Sadler KV; Bowes J; Rowlands CF; Perez-Becerril C; van der Meer CM; King AT; Rutherford SA; Pathmanaban ON; Hammerbeck-Ward C; Lloyd SKW; Freeman SR; Williams R; Hannan CJ; Lewis D; Eyre S; Evans DG; Smith MJ
    Brain; 2023 Jul; 146(7):2861-2868. PubMed ID: 36546557
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. lztr1 Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL.
    Ko A; Hasanain M; Oh YT; D'Angelo F; Sommer D; Frangaj B; Tran S; Bielle F; Pollo B; Paterra R; Mokhtari K; Soni RK; Peyre M; Eoli M; Papi L; Kalamarides M; Sanson M; Iavarone A; Lasorella A
    Cancer Discov; 2023 Mar; 13(3):702-723. PubMed ID: 36445254
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Redefining germline predisposition in children with molecularly characterized ependymoma: a population-based 20-year cohort.
    Foss-Skiftesvik J; Stoltze UK; van Overeem Hansen T; Ahlborn LB; Sørensen E; Ostrowski SR; Kullegaard SMA; Laspiur AO; Melchior LC; Scheie D; Kristensen BW; Skjøth-Rasmussen J; Schmiegelow K; Wadt K; Mathiasen R
    Acta Neuropathol Commun; 2022 Aug; 10(1):123. PubMed ID: 36008825
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. lztr1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis.
    Farncombe KM; Thain E; Barnett-Tapia C; Sadeghian H; Kim RH
    BMC Med Genomics; 2022 Jul; 15(1):160. PubMed ID: 35840934
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. WP1066 induces cell death in a schwannomatosis patient-derived schwannoma cell line.
    Allaf A; Victoria B; Rosario R; Misztal C; Humayun Gultekin S; Dinh CT; Fernandez-Valle C
    Cold Spring Harb Mol Case Stud; 2022 Jun; 8(4):. PubMed ID: 35732500
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Screening of potential novel candidate genes in schwannomatosis patients.
    Perez-Becerril C; Wallace AJ; Schlecht H; Bowers NL; Smith PT; Gokhale C; Eaton H; Charlton C; Robinson R; Charlton RS; Evans DG; Smith MJ
    Hum Mutat; 2022 Oct; 43(10):1368-1376. PubMed ID: 35723634
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes.
    Wang M; Banik I; Shain AH; Yeh I; Bastian BC
    Genome Med; 2022 Jun; 14(1):65. PubMed ID: 35706047
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.
    Plotkin SR; Messiaen L; Legius E; Pancza P; Avery RA; Blakeley JO; Babovic-Vuksanovic D; Ferner R; Fisher MJ; Friedman JM; Giovannini M; Gutmann DH; Hanemann CO; Kalamarides M; Kehrer-Sawatzki H; Korf BR; Mautner VF; MacCollin M; Papi L; Rauen KA; Riccardi V; Schorry E; Smith MJ; Stemmer-Rachamimov A; Stevenson DA; Ullrich NJ; Viskochil D; Wimmer K; Yohay K; ; Huson SM; Wolkenstein P; Evans DG
    Genet Med; 2022 Sep; 24(9):1967-1977. PubMed ID: 35674741
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Sustained response to bevacizumab in a patient with mosaic neurofibromatosis type 2 carrying the
    Basenach E; Förster A; Raab P; Alzein S; Schmidt G; Krauss JK; Schlegelberger B; Heidenreich F; Auber B; Hartmann C; Wiese B; Weber RG
    Clin Neuropathol; 2022; 41(4):162-167. PubMed ID: 35445657
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Comparison of the frequency of loss-of-function lztr1 variants between schwannomatosis patients and the general population.
    Deng F; Evans DG; Smith MJ
    Hum Mutat; 2022 Jul; 43(7):919-927. PubMed ID: 35391499
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis.
    Evans DG; Mostaccioli S; Pang D; Fadzil O Connor M; Pittara M; Champollion N; Wolkenstein P; Thomas N; Ferner RE; Kalamarides M; Peyre M; Papi L; Legius E; Becerra JL; King A; Duff C; Stivaros S; Blanco I
    Eur J Hum Genet; 2022 Jul; 30(7):812-817. PubMed ID: 35361920
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Multiple Meningiomas as a Criterion for the Diagnosis of Neurofibromatosis Type 2 and Other tumor Predisposition Syndromes.
    Hannan CJ; Hammerbeck-Ward C; Pathmanaban ON; Smith MJ; Rutherford SA; Lloyd SK; Mackenzie Freeman SR; Wallace AJ; King AT; Richard Evans DG
    Neurosurgery; 2022 Jun; 90(6):793-799. PubMed ID: 35343466
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis.
    Farshidfar F; Rhrissorrakrai K; Levovitz C; Peng C; Knight J; Bacchiocchi A; Su J; Yin M; Sznol M; Ariyan S; Clune J; Olino K; Parida L; Nikolaus J; Zhang M; Zhao S; Wang Y; Huang G; Wan M; Li X; Cao J; Yan Q; Chen X; Newman AM; Halaban R
    Nat Commun; 2022 Feb; 13(1):898. PubMed ID: 35197475
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Targeted massively parallel sequencing of candidate regions on chromosome 22q predisposing to multiple schwannomas: An analysis of 51 individuals in a single-center experience.
    Piotrowski A; Koczkowska M; Poplawski AB; Bartoszewski R; Króliczewski J; Mieczkowska A; Gomes A; Crowley MR; Crossman DK; Chen Y; Lao P; Serra E; Llach MC; Castellanos E; Messiaen LM
    Hum Mutat; 2022 Jan; 43(1):74-84. PubMed ID: 34747535
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pathogenic noncoding variants in the neurofibromatosis and schwannomatosis predisposition genes.
    Perez-Becerril C; Evans DG; Smith MJ
    Hum Mutat; 2021 Oct; 42(10):1187-1207. PubMed ID: 34273915
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Skull Base tumors: Neuropathology and Clinical Implications.
    Bi WL; Santagata S
    Neurosurgery; 2022 Mar; 90(3):243-261. PubMed ID: 34164689
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis.
    Tamura R
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072574
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Typical 22q11.2 deletion syndrome appears to confer a reduced risk of schwannoma.
    Evans DG; Messiaen LM; Foulkes WD; Irving REA; Murray AJ; Perez-Becerril C; Rivera B; McDonald-McGinn DM; Stevenson DA; Smith MJ
    Genet Med; 2021 Sep; 23(9):1779-1782. PubMed ID: 33879870
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Diagnostic Pathology of tumors of Peripheral Nerve.
    Belakhoua SM; Rodriguez FJ
    Neurosurgery; 2021 Feb; 88(3):443-456. PubMed ID: 33588442
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. lztr1-related spinal schwannomatosis and 7q11.23 duplication syndrome: A complex phenotype with dual diagnosis.
    Muthusamy K; Mrugala MM; Bendok BR; Dhamija R
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1560. PubMed ID: 33269527
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.